Opinion
Learning From Canada’s Mistakes; Why Firms Should Double Down On Medical Cannabis In Europe
By: Max Monahan-Ellison AS hype and excitement builds around the potential for recreational cannabis legalization in some European countries, it’s an opportune time to share learnings from Canadian recreational legalization and argue that the medical market should remain a priority for companies.